$ 242.37
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Overvalued vs peers
About
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, overpriced on
Target Price
The average target price of STE is 256 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
